Nicola Vanacore to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Nicola Vanacore has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.044
-
Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Sep 03; 22(1):584.
Score: 0.044